COVID-19 and return to campus information.
University of California, Riverside
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces
Novel agents 135H11 and 135H12 move research closer to drug development
UC Riverside’s Maurizio Pellecchia receives grants totaling nearly $2.5 million from National Academy of Sciences, Engineering, and Medicine; and National Institute of Neurological Disorders and Stroke
A UCR research team has discovered a way for chemotherapy drug paclitaxel to target migrating cancer cells